The presence of β-amyloid in the brain may represent a preclinical stage of Alzheimer’s disease, but this is controversial. Jagust examines the association between β-amyloid and biomarkers of Alzheimer’s disease in cognitively normal older people, concluding that β-amyloid is harmful to the brain in a manner consistent with Alzheimer’s disease.